Intercept Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Intercept Pharmaceuticals Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Intercept Pharmaceuticals Inc Strategy Report

  • Understand Intercept Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Intercept Pharmaceuticals Inc: Executives

The following section provides information on Intercept Pharmaceuticals Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Intercept Pharmaceuticals Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Vivek Devaraj

Chairman; President - U.S. Executive Board

Mr. Vivek Devaraj is the Chairman and President of US of the company. Prior to this, he served as the Director of the International Business Unit at Alfasigma Group. Previously, he served in Sandoz, Innovative Medicines and CIBA Vision business divisions at the Novartis group.

Read Hide full bio of Vivek Devaraj

Rocco Venezia

Chief Financial Officer Senior Management Since: 2023

Mr. Rocco Venezia has been serving as the Chief Financial Officer of the company since 2023. Prior to this, Mr. Venezia served as the company's Chief Accounting Officer and Corporate Controller. Prior to that, he served as the Assistant Corporate Controller at IKARIA Inc, which is part of Mallinckrodt Pharmaceuticals, from 2013 to 2016.

Read Hide full bio of Rocco Venezia

Kathleen Munster

Senior Vice President - Technical Operations; Chief Quality Officer Senior Management

Ms. Kathleen Munster is the Chief Quality Officer and Senior Vice President- Technical Operations of the company. Prior to that, she served as the Head of Business Initiatives & Operational Excellence and Senior Vice President, Enabling Functions (Quality, Facilities, and IT) at 2seventy bio. Previously, she also served as the Vice President, Biologics, Cell & Gene Therapy Quality at Catalent Pharma Solutions. She also served in various roles at Bristol-Myers Squibb and Merck & Co., Inc.

Read Hide full bio of Kathleen Munster

Sangeeta Sawhney

Head - U.S. Research and Development; Senior Vice President Senior Management

Richard Johnson

Senior Vice President; Head - U.S. Human Resources Senior Management
Gain a 360-degree view of Intercept Pharmaceuticals Inc and make more informed decisions for your business Gain a 360-degree view of Intercept Pharmaceuticals Inc and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code